+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Narcolepsy Drug"

Narcolepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Narcolepsy Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 363 Pages
  • Global
From
From
From
Narcolepsy - Pipeline Insight, 2024 - Product Thumbnail Image

Narcolepsy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 75 Pages
  • Global
From
Sleeping Aids Global Market Report 2024 - Product Thumbnail Image

Sleeping Aids Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Narcolepsy Drug market is a subset of the Central Nervous System Drugs market. Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and sudden, uncontrollable episodes of sleep. Narcolepsy drugs are used to reduce the symptoms of the disorder, such as excessive daytime sleepiness, cataplexy, and sleep paralysis. These drugs are typically stimulants, such as modafinil, armodafinil, and methylphenidate. Other drugs used to treat narcolepsy include tricyclic antidepressants, sodium oxybate, and clonidine. Some companies in the Narcolepsy Drug market include Cephalon, Inc., Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more